Vertex Pharmaceuticals Statistics
Total Valuation
VRTX has a market cap or net worth of $127.80 billion. The enterprise value is $116.14 billion.
| Market Cap | 127.80B |
| Enterprise Value | 116.14B |
Important Dates
The next confirmed earnings date is Monday, November 2, 2026, after market close.
| Earnings Date | Nov 2, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
VRTX has 253.46 million shares outstanding. The number of shares has decreased by -0.85% in one year.
| Current Share Class | 253.46M |
| Shares Outstanding | 253.46M |
| Shares Change (YoY) | -0.85% |
| Shares Change (QoQ) | -0.43% |
| Owned by Insiders (%) | 0.20% |
| Owned by Institutions (%) | 96.90% |
| Float | 252.68M |
Valuation Ratios
The trailing PE ratio is 29.49 and the forward PE ratio is 39.17. VRTX's PEG ratio is 2.94.
| PE Ratio | 29.49 |
| Forward PE | 39.17 |
| PS Ratio | 10.20 |
| Forward PS | 9.21 |
| PB Ratio | 6.34 |
| P/TBV Ratio | 6.85 |
| P/FCF Ratio | 33.83 |
| P/OCF Ratio | 29.92 |
| PEG Ratio | 2.94 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 22.89, with an EV/FCF ratio of 30.76.
| EV / Earnings | 26.51 |
| EV / Sales | 9.28 |
| EV / EBITDA | 22.89 |
| EV / EBIT | 23.79 |
| EV / FCF | 30.76 |
Financial Position
The company has a current ratio of 3.19, with a Debt / Equity ratio of 0.10.
| Current Ratio | 3.19 |
| Quick Ratio | 2.54 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | 0.37 |
| Debt / FCF | 0.52 |
| Interest Coverage | 369.14 |
Financial Efficiency
Return on equity (ROE) is 23.54% and return on invested capital (ROIC) is 28.80%.
| Return on Equity (ROE) | 23.54% |
| Return on Assets (ROA) | 11.93% |
| Return on Invested Capital (ROIC) | 28.80% |
| Return on Capital Employed (ROCE) | 20.90% |
| Weighted Average Cost of Capital (WACC) | 5.71% |
| Revenue Per Employee | $1.97M |
| Profits Per Employee | $688,313 |
| Employee Count | 6,400 |
| Asset Turnover | 0.49 |
| Inventory Turnover | 3.47 |
Taxes
In the past 12 months, VRTX has paid $869.30 million in taxes.
| Income Tax | 869.30M |
| Effective Tax Rate | 16.48% |
Stock Price Statistics
The stock price has increased by +24.45% in the last 52 weeks. The beta is 0.28, so VRTX's price volatility has been lower than the market average.
| Beta (5Y) | 0.28 |
| 52-Week Price Change | +24.45% |
| 50-Day Moving Average | 518.17 |
| 200-Day Moving Average | 473.61 |
| Relative Strength Index (RSI) | 38.17 |
| Average Volume (20 Days) | 975,385 |
Short Selling Information
The latest short interest is 4.72 million, so 1.86% of the outstanding shares have been sold short.
| Short Interest | 4.72M |
| Short Previous Month | 4.66M |
| Short % of Shares Out | 1.86% |
| Short % of Float | 1.87% |
| Short Ratio (days to cover) | 4.72 |
Income Statement
In the last 12 months, VRTX had revenue of $12.59 billion and earned $4.41 billion in profits. Earnings per share was $17.18.
| Revenue | 12.59B |
| Gross Profit | 6.92B |
| Operating Income | 4.91B |
| Pretax Income | 5.27B |
| Net Income | 4.41B |
| EBITDA | 5.10B |
| EBIT | 4.91B |
| Earnings Per Share (EPS) | $17.18 |
Balance Sheet
The company has $7.85 billion in cash and $1.98 billion in debt, with a net cash position of $11.66 billion or $46.02 per share.
| Cash & Cash Equivalents | 7.85B |
| Total Debt | 1.98B |
| Net Cash | 11.66B |
| Net Cash Per Share | $46.02 |
| Equity (Book Value) | 20.25B |
| Book Value Per Share | 79.92 |
| Working Capital | 8.61B |
Cash Flow
In the last 12 months, operating cash flow was $4.29 billion and capital expenditures -$496.80 million, giving a free cash flow of $3.80 billion.
| Operating Cash Flow | 4.29B |
| Capital Expenditures | -496.80M |
| Depreciation & Amortization | 190.90M |
| Net Borrowing | -5.40M |
| Free Cash Flow | 3.80B |
| FCF Per Share | $14.98 |
Margins
Gross margin is 54.96%, with operating and profit margins of 39.00% and 35.00%.
| Gross Margin | 54.96% |
| Operating Margin | 39.00% |
| Pretax Margin | 41.90% |
| Profit Margin | 35.00% |
| EBITDA Margin | 40.52% |
| EBIT Margin | 39.00% |
| FCF Margin | 30.16% |
Dividends & Yields
VRTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 0.85% |
| Shareholder Yield | 0.85% |
| Earnings Yield | 3.43% |
| FCF Yield | 2.96% |
Analyst Forecast
The average price target for VRTX is $571.39, which is 13.32% higher than the current price. The consensus rating is "Buy".
| Price Target | $571.39 |
| Price Target Difference | 13.32% |
| Analyst Consensus | Buy |
| Analyst Count | 32 |
| Revenue Growth Forecast (3Y) | 11.06% |
| EPS Growth Forecast (3Y) | 8.25% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 24, 2000. It was a forward split with a ratio of 2:1.
| Last Split Date | Aug 24, 2000 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
VRTX has an Altman Z-Score of 11.58 and a Piotroski F-Score of 5.
| Altman Z-Score | 11.58 |
| Piotroski F-Score | 5 |